Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.
By E. Mcfadden, E. Stabile, E. Regar, E. Cheneau, A. Ong, T. Kinnaird, W. Suddath, N. Weissman, R. Torguson, K. Kent and 4 more. The Lancet, 2004
1,503 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/76a9e248754285e7fd1c1769a07191ad737f3602
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- Incomplete Stent Apposition and Very Late Stent Thrombosis After Drug-Eluting Stent Implantation (2007, methodology): “17,18 Several mechanisms of ISA have been proposed and are depicted schematically in Figure 5, as follows: (1) positive arterial remodeling with an increase of EEM out of proportion to the increase in persistent plaque and media; (2) a decrease in plaque and media due to dissolution of jailed thromb”
- ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiov (2007, background): “5 years after implantation, particularly in the context of discontinuation of antiplatelet agents before noncardiac surgery (52,53).”
- A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. (2006, background): “Raizner 40 Case series reporting on adverse clinical events after non-cardiac surgery in patients treated with coronary stents McFadden et al.(24) (2004) 2003–2004 P.”
- [2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.] (2018, background): “The need to investigate longer DAPT regimens firstly arose from concerns over late and very late stent thrombosis occurring after first-generation drug-eluting stent (DES) implantation [3].”
- Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement: Results From the PREMIER Registry (2006, neutral): “No healthcare insurance/self-pay 36 (9) 6 (9) 0.”
- Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. (2005, neutral): “Current smoking 379 (17) 169 (16) 210 (18)”